Avid Bioservices Inc (CDMO)

[erg0t250]

http://seekingalpha.com/article/1059001-peregrine-pharmaceuticals-ceo-discusses-f2q-2013-results-earnings-call-transcript?page=4&p=qanda&l=last

Joe Pantgnis Asked SK
"
Sure. And then the other 2 questions that I have is, you mentioned with regard to front-line lung and also the pancreatic data, saying, 'in the coming months', just wanted to know if you have any further granularity on timing, especially since, I guess -- well, I don't know what sort of disclosures you guys are getting with regard to the event rates in those studies."

SK replies

"All along, of course, the front-line data and pancreatic data have been sort of looming out there and obviously, over time, will mature. As far as the trigger points for those data points, it's really just -- these are event-driven endpoints, and it's good for patients the longer they go out. (timeline question answered) Having said that, when we do reach, what we think is a good solid result from the studies, and we will be in a position to put those out kind of as they become available. And obviously, there will likely be a disconnect between those 2 particular clinical results. "